Anaplastic thyroid carcinoma with diffuse thoracic skin metastasis: A case report
- Authors:
- Serdar Altınay
- Betül Taş
- Aynur Özen
- Pelin Altınok Süt
View Affiliations
Affiliations: Department of Pathology, Bağcılar Training and Research Hospital, Istanbul 34203, Turkey, Department of Dermatology, Bağcılar Training and Research Hospital, Istanbul 34203, Turkey, Department of Nuclear Medicine, Bağcılar Training and Research Hospital, Istanbul 34203, Turkey, Department of Radiation Oncology, Bağcılar Training and Research Hospital, Istanbul 34203, Turkey
- Published online on: April 4, 2014 https://doi.org/10.3892/ol.2014.2036
-
Pages:
1767-1770
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Anaplastic thyroid carcinoma is a significantly fatal endocrine neoplasm, with an average survival time of 4‑12 months following diagnosis. The present study reports the case of a 57‑year‑old male patient who presented to the Bağcılar Training and Research Hospital (Istanbul, Turkey) due to swelling in the neck and difficulty swallowing. The jugular mass biopsy results were consistent with a diagnosis of anaplastic thyroid cancer. The patient was regarded to have advanced‑stage subcarinal, paratracheal, aortopulmonary, trancheobronchial and mediastinal lymphadenopathies and exhibited a good prognosis following chemotherapy. However, the patient succumbed one month later due to the emergence of diffuse skin lesions. The histopathological and immunohistochemical assessment of the skin biopsy displayed the characteristics of the underlying thyroid carcinoma.
View References
|
1
|
Gilliland FD, Hunt WC, Morris DM and Key
CR: Prognostic factors for thyroid carcinoma. A population-based
study of 15,698 cases from the Surveillance, Epidemiology and End
Results (SEER) program 1973–1991. Cancer. 79:564–573.
1997.PubMed/NCBI
|
|
2
|
Are C and Shaha AR: Anaplastic thyroid
carcinoma: biology, pathogenesis, prognostic factors, and treatment
approaches. Ann Surg Oncol. 13:453–464. 2006. View Article : Google Scholar
|
|
3
|
Leonhardt JM and Heymann WR: Thyroid
disease and the skin. Dermatol Clin. 20:473–481. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dahl PR, Brodland DG, Goellner JR and Hay
ID: Thyroid carcinoma metastatic to the skin: a cutaneous
manifestation of a widely disseminated malignancy. J Am Acad
Dermatol. 36:531–537. 1997. View Article : Google Scholar
|
|
5
|
Koller EA, Tourtelot JB, Pak HS, Cobb MW,
Moad JC and Flynn EA: Papillary and follicular thyroid carcinoma
metastatic to the skin: a case report and review of the literature.
Thyroid. 8:1045–1050. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Barr R and Dann F: Anaplastic thyroid
carcinoma metastatic to skin. J Cutan Pathol. 1:201–206. 1974.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lau SK, Luthringer DJ and Eisen RN:
Thyroid transcription factor-1: a review. Appl Immunohistochem Mol
Morphol. 10:97–102. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nel CJ, van Heerden JA, Goellner JR,
Gharib H, McConahey WM, Taylor WF and Grant CS: Anaplastic
carcinoma of the thyroid: a clinicopathologic study of 82 cases.
Mayo Clin Proc. 60:51–58. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shimaoka K, Schoenfeld DA, DeWys WD,
Creech RH and DeConti R: A randomized trial of doxorubicin versus
doxorubicin plus cisplatin in patients with advanced thyroid
carcinoma. Cancer. 56:2155–2160. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ain KB, Egorin MJ and DeSimone PA:
Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2
trial using ninety-six-hour infusion. Collaborative Anaplastic
Thyroid Cancer Health Intervention Trials (CATCHIT) Group. Thyroid.
10:587–594. 2000. View Article : Google Scholar : PubMed/NCBI
|
